Veradermics IPO Slated to Hit Top of $14-$16 Range Amid Heavy Demand
Veradermics Inc.'s initial public offering is expected to price at the top of its marketed $14 to $16 range on Tuesday, with the deal reported to be multiple times oversubscribed. Investors are being warned that allocations will likely be limited. A filing shows Eli Lilly has expressed interest in buying up to 4.9% of Veradermics' outstanding share…